Joseph Anthony D'Alessio

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD48 antibodies, antibody drug conjugates, and uses thereof
- Patent number 11,999,786
- Issue date Jun 4, 2024
- Novartis AG
- Joseph Anthony D'Alessio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies to PMEL17 and conjugates thereof
- Patent number 11,779,649
- Issue date Oct 10, 2023
- Novartis AG
- Matthew Burger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SELECTIVE BCL-XL PROTAC COMPOUNDS AND METHODS OF USE
- Publication number 20240376094
- Publication date Nov 14, 2024
- LES LABORATOIRES SERVIER
- András Herner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD48 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND USES THEREOF
- Publication number 20240352122
- Publication date Oct 24, 2024
- Novartis AG
- Joseph Anthony D'ALESSIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF
- Publication number 20240299574
- Publication date Sep 12, 2024
- Novartis AG
- Matthew Burger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
- Publication number 20240269304
- Publication date Aug 15, 2024
- Novartis AG
- Matthew T. Burger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES AND METHODS FOR MAKING THEREOF
- Publication number 20240252668
- Publication date Aug 1, 2024
- Novartis AG
- Liqiong Fan
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF
- Publication number 20240189439
- Publication date Jun 13, 2024
- Novartis AG
- Matthew Burger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE BCL-XL PROTAC COMPOUNDS AND METHODS OF USE
- Publication number 20240182464
- Publication date Jun 6, 2024
- Les Laboratoirens Serviece
- András Herner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
- Publication number 20240042051
- Publication date Feb 8, 2024
- Novartis AG
- Matthew T. Burger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
- Publication number 20230092679
- Publication date Mar 23, 2023
- Novartis AG
- Matthew T. Burger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES HAVING LINKERS COMPRISING HYDROPHILIC GROUPS
- Publication number 20230091510
- Publication date Mar 23, 2023
- Novartis AG
- Zhuoliang CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
- Publication number 20230081720
- Publication date Mar 16, 2023
- Novartis AG
- Matthew T. Burger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD48 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND USES THEREOF
- Publication number 20220162308
- Publication date May 26, 2022
- NOVARTS AG
- Joseph Anthony D'ALESSIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF
- Publication number 20200197528
- Publication date Jun 25, 2020
- Novartis AG
- Matthew BURGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES
- Publication number 20190194315
- Publication date Jun 27, 2019
- Novartis AG
- Tinya ABRAMS
- C07 - ORGANIC CHEMISTRY

Joseph Anthony D'Alessio

Person

Patents Grantslast 30 patents

Anti-CD48 antibodies, antibody drug conjugates, and uses thereof

Antibodies to PMEL17 and conjugates thereof

Patents Applicationslast 30 patents

SELECTIVE BCL-XL PROTAC COMPOUNDS AND METHODS OF USE

ANTI-CD48 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND USES THEREOF

ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF

BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

ANTIBODY DRUG CONJUGATES AND METHODS FOR MAKING THEREOF

ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF

SELECTIVE BCL-XL PROTAC COMPOUNDS AND METHODS OF USE

MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

ANTIBODY DRUG CONJUGATES HAVING LINKERS COMPRISING HYDROPHILIC GROUPS

MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

ANTI-CD48 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND USES THEREOF

ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF

ANTIBODY DRUG CONJUGATES